Maintenance / Service
PRODUCTS
-
Werum PAS-X Savvy accelerates bioprocessing with real-time data management, visualization, and analysis—enabling agile development, robust decision-making, cost reduction, and consistent quality across pharma and biotech production lifecycles.
-
Mikart’s small-scale non-GMP lab accelerates development by enabling rapid testing and iteration at a lower cost.
-
Recipharm Advanced Bio offers industry-leading biologics development services to support global clients in all clinical phases and global regulatory arenas. Our comprehensive development services include both process and formulation development.
-
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
-
This content was created by Boehringer Ingelheim BioXcellence™
Microbial product market is a market with attractive growth – and that growth is coming from diverse molecule formats and process formats where Boehringer Ingelheim in Vienna has outstanding development and manufacturing experience. We’re proud to be pioneers in the microbial field, with a track record of success going back to the 1980s and our work on recombinant interferons. Since then, we have brought 20 microbial manufactured products to the global market: some our own, some as trusted manufacturing partner.
WHITE PAPERS AND CASE STUDIES
-
The Answer To Your Pharmacovigilance Challenges: AI-Powered Adverse Event Detection
A proven, AI-powered safety platform can accelerate adverse event detection and safety data extraction to ease the burden on safety professionals and better protect patients.
-
Forget About Isolators: Switching From Manual Vial To Automated Bag Filling
Discover how transitioning from manual vial filling to single-use bag systems can reduce contamination risk, improve accuracy, and enhance GMP compliance in biopharmaceutical manufacturing.
-
How Bend Bioscience Standardized Operations And Boosted Compliance
Discover how Bend Bioscience replaced its outdated CMMS with RAM to achieve rapid compliance, boost efficiency across facilities, and cut operational costs by 25%.
-
Molecular Approaches To Streamline Cell Therapy Product Analytical Testing
Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.
-
The Evolution Of SDV, SDR, And RBQM In Clinical Trial Data Quality
Explore the inefficiency of complete SDV and how the adoption of technologies like centralized monitoring, remote SDR, and targeted SDV can enhance data integrity and cost-effectiveness.
-
Leveraging Flow Chemistry
Discover how continuous processing cuts waste, improves efficiency, and supports safer, scalable reactions while helping teams meet sustainability goals and speed development.
-
Novel Platform For Execution Of Pragmatic Studies Boosts Cancer Trial Efficiency
Learn how Flatiron partnered with Genentech and Foundation Medicine to develop a novel platform for the execution of pragmatic studies.
-
Operational Success By Strategic Investment
Explore how infrastructure, equipment strategy, and advanced technologies shape a more reliable path for scaling sterile injectable programs.
-
Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025)
Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.
-
Quality: The Link Between Platform, Processes, And Patients
Quality management in healthcare and life sciences is crucial for optimizing patient health. Learn how modern quality management systems optimize patient outcomes, enhance safety, and drive operational efficiency.
-
Lean Six Sigma Methodology Drives Cost Savings: 2 Success Stories
Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.
-
A Guide For Quality Professionals In Healthcare And Life Sciences
Discover a guide for quality professionals that highlights essential principles and strategies for maintaining data accuracy, compliance, and innovation to ensure high-quality data in healthcare and life sciences.
NEWS
-
GoFormz And AASHTOWare Launch Data Alliance To Modernize DOT Field Operations11/17/2025
GoFormz, a leading digital forms and workflow automation platform, today announced a Data Alliance with AASHTOWare, a trusted solution designed for and used by state departments of transportation (DOTs) across the U.S. The alliance leverages AASHTOWare OpenAPI and GoFormz's mobile-friendly, no-code platform to streamline data collection, automate workflows, and strengthen compliance for DOTs.
-
ITM And Alpha-9 Oncology Enter Into Supply Agreement For Therapeutic Medical Radioisotope Actinium-2254/24/2025
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a clinical-stage biotechnology company advancing a distinctive portfolio of differentiated and highly targeted radiopharmaceuticals, today announced the signing of a supply agreement for Actinium-225 (Ac-225) to support the development of Alpha-9’s radiopharmaceutical programs.
-
How Fairgrounds (Previously AgPile) Connects Data And Crop Breeders – With Early Examples8/27/2025
In early 2025, CGIAR received a grant from the Gates Foundation to develop AgPile, a FAIR, federated and collaborative data platform that references and organizes access to datasets from CGIAR, its Centers, and partners.
-
Sutro Biopharma And Boehringer Ingelheim BioXcellence™ Collaboration: Established First-In-Class Cell-Free Capabilities At Commercial Scale1/7/2025
Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc. today announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture luveltamab tazevibulin (luvelta), Sutro’s Tubulin FRα-targeting antibody-drug conjugate (ADC) designed to treat a broad range of patients with ovarian cancer and other FRα expressing cancers.